State Street’s ACELYRIN SLRN Stock Holding History

State Street’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,420,068	Closed	-$3.51M	–	4314
2025 Q1	$3.51M	Sell	1,420,068 -21,205	-1%	-$50.4K	﹤0.01%	3023
2024 Q4	$4.53M	Buy	1,441,273 +168,177	+13%	+$814K	﹤0.01%	3019
2024 Q3	$6.28M	Buy	1,273,096 +116,094	+10%	+$599K	﹤0.01%	2852
2024 Q2	$5.1M	Buy	1,157,002 +28,682	+3%	+$134K	﹤0.01%	2920
2024 Q1	$7.62M	Buy	1,128,320 +463,382	+70%	+$3.52M	﹤0.01%	2735
2023 Q4	$4.96M	Sell	664,938 -1,315,378	-66%	-$11.2M	﹤0.01%	2948
2023 Q3	$20.1M	Buy	1,980,316 +1,863,316	+1,593%	+$39.6M	﹤0.01%	2176
2023 Q2	$2.45M	Buy	+117,000	New	+$2.39M	﹤0.01%	3317

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State Street's SLRN Position: Q2 2025 in Review

State Street sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 1,420,068 shares — an estimated $3.51M sold.

State Street first reported a position in SLRN in Q2 2023 and held it in 8 quarters. The position peaked at $20.1M in Q3 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

State Street reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
State Street sold 1,420,068 ACELYRIN shares in Q2 2025, an estimated $3.51M.
State Street first reported a position in ACELYRIN in Q2 2023 and held it in 8 quarters.
State Street's ACELYRIN position peaked at $20.1M in Q3 2023.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.